Milestone Pharmaceuticals Inc. (MIST)
NASDAQ: MIST · Real-Time Price · USD
1.155
-0.035 (-2.94%)
Aug 28, 2026, 2:22 PM EDT - Market open

Milestone Pharmaceuticals Stock Forecast

Stock Price Forecast

According to 7 analysts polled by S&P Global, Milestone Pharmaceuticals stock has a consensus rating of "Strong Buy" and an average price target of $5.86. The average 1-year stock price forecast is 407.36% higher than the current stock price, while the lowest is $2.00 (+73.16%) and the highest is $8.00 (+592.64%).

Price Target: $5.86 (+407.36%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$2.00$5.86$7.00$8.00
Change+73.16%+407.36%+506.06%+592.64%

Analyst Ratings

The average analyst rating for Milestone Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingFeb '26Mar '26Apr '26May '26Jul '26Aug '26
Strong Buy334445
Buy111111
Hold111111
Sell000000
Strong Sell000000
Total556667

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Cantor Fitzgerald
Cantor Fitzgerald
Buy
Initiates
$3
BuyInitiates$3+159.74%Aug 20, 2026
TD Cowen
TD Cowen
Buy
Maintains
$8
BuyMaintains$8+592.64%Aug 13, 2026
Wells Fargo
Wells Fargo
Buy
Maintains
$7
BuyMaintains$7+506.06%Aug 13, 2026
H.C. Wainwright
H.C. Wainwright
Buy
Reiterates
$8
BuyReiterates$8+592.64%Aug 12, 2026
Piper Sandler
Piper Sandler
Buy
Reiterates
$7
BuyReiterates$7+506.06%May 14, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
3.83M
from 1.55M
Increased by 147.62%
Revenue Next Year
22.14M
from 3.83M
Increased by 478.29%
EPS This Year
-0.84
from -0.75
EPS Next Year
-0.77
from -0.84
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
15.00M5.00M1.00M-1.55M3.83M
Revenue Growth
--66.67%-80.00%--147.62%
Operating Income
-43.07M-59.64M-61.10M-42.10M-62.14M-107.63M
Net Income
-42.85M-58.39M-59.69M-41.52M-63.06M-116.74M
EPS
-----0.75-0.84
Free Cash Flow
-17.05M-31.36M-28.29M-18.12M-28.90M-81.50M
No. Analysts
-----7
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High6.0M
Avg3.8M
Low2.8M

Revenue Growth

Revenue Growth202620272028
High
288.1%
Avg
147.6%
Low
81.1%

EPS Forecast

EPS202620272028
High-0.77
Avg-0.84
Low-0.90

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-